Umeclidinium for treating COPD: an evaluation of pharmacologic properties, safety and clinical use.
about
Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD)Efficacy and Safety of Twice-Daily Glycopyrrolate Versus Placebo in Patients With COPD: The GEM2 Study.Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).Treatment options for moderate-to-very severe chronic obstructive pulmonary disease.Muscarinic Receptor Antagonists.Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β-Agonist Therapy: An Integrated Post Hoc Analysis
P2860
Umeclidinium for treating COPD: an evaluation of pharmacologic properties, safety and clinical use.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Umeclidinium for treating COPD ...... ties, safety and clinical use.
@en
type
label
Umeclidinium for treating COPD ...... ties, safety and clinical use.
@en
prefLabel
Umeclidinium for treating COPD ...... ties, safety and clinical use.
@en
P2093
P2860
P1476
Umeclidinium for treating COPD ...... ties, safety and clinical use.
@en
P2093
Amit Asija
Rajapriya Manickam
Wilbert S Aronow
P2860
P304
P356
10.1517/14740338.2014.968550
P407
P577
2014-10-08T00:00:00Z